Introduction
For most of the history of medical device regulation, cybersecurity was a niche technical concern handled quietly by software engineers, mentioned briefly in a design history file and rarely discussed in a regulatory strategy meeting. That has changed. Connected devices, from infusion pumps to imaging systems to implantables with wireless telemetry, now carry cybersecurity expectations that touch premarket submissions, postmarket surveillance, and quality systems all at once. For regulatory affairs professionals working in medical devices, this shift has created a genuinely new category of work, and companies are still figuring out who inside the organization should own it.
Why This Became a Regulatory Affairs Issue, Not Just an Engineering One
Cybersecurity risk in a connected device is a patient safety issue, which is precisely the framing that pulls it into regulatory affairs' territory rather than leaving it purely as an IT or software engineering concern. A device that can be remotely accessed or manipulated is a device with a safety and effectiveness profile that a regulator needs to understand before clearing or approving it. FDA formalized this thinking well before it had explicit statutory authority to enforce it, publishing premarket and postmarket cybersecurity guidance for years before Congress gave the agency clearer authority to require cybersecurity information in premarket submissions for devices that meet the statutory definition of a "cyber device." That authority changed what used to be a strong recommendation into something closer to a submission requirement, and regulatory affairs teams are the ones who have to make sure a submission actually satisfies it.
In practice, this means a premarket submission for a qualifying connected device now generally needs to address how the sponsor will monitor, identify, and address postmarket cybersecurity vulnerabilities, provide a plan for coordinated vulnerability disclosure, and include a software bill of materials describing the commercial, open-source, and off-the-shelf software components in the device. None of that content is something a regulatory affairs specialist can write alone, but assembling it into a coherent, reviewable submission section, and knowing what a reviewer will actually expect to see, has become regulatory affairs' job.
The New Cross-Functional Work This Creates
The practical effect inside a device company is a new layer of coordination that did not used to exist in this form. Regulatory affairs now needs a working relationship with security engineering or product security teams the way it has long had one with clinical and quality. That relationship is not always easy to build, because the two functions think about risk differently: a security engineer is trained to think in terms of exploitability and attack surface, while a regulatory affairs professional is trained to think in terms of what a reviewer needs to see documented and how a claim will hold up during an audit. Getting a security team to produce documentation in a form that supports a regulatory submission, rather than an internal engineering risk register that was never meant to leave the building, is a real translation problem, and it is one that falls to regulatory affairs to solve.
This has also created new demand for regulatory professionals who can speak enough of the security vocabulary to ask the right questions: what does the software bill of materials actually cover, has a threat model been documented for this device's specific connectivity features, and what is the plan if a vulnerability is discovered in a third-party component six months after clearance. A regulatory affairs specialist does not need to be able to perform a penetration test, but being unable to have an informed conversation with a security engineer, or not knowing what questions to ask, increasingly shows up as a real capability gap during hiring.
Postmarket Obligations Are Where This Gets Harder
The premarket submission content, while new, is at least a defined, one-time deliverable. The postmarket side of medical device cybersecurity is where the ongoing regulatory affairs workload actually lives. A cleared device with connectivity features is expected to have an active vulnerability monitoring and disclosure process for its entire time on the market, not just at the point of clearance. When a vulnerability is identified in a widely used software component, a device manufacturer needs a process for assessing whether its products are affected, communicating with customers and regulators as appropriate, and documenting that the assessment happened even when the conclusion is that no action is needed. Regulatory affairs is often the function that has to make sure this process exists on paper, gets followed in practice, and produces a defensible record, which is a different kind of ongoing responsibility than the submission-and-clearance rhythm most device regulatory professionals are used to.
What This Means for Hiring
Job postings in medical device regulatory affairs increasingly mention cybersecurity submission experience, software bill of materials familiarity, or postmarket vulnerability management as a preferred qualification, particularly for companies making connected devices, infusion systems, imaging equipment, or anything with wireless or network connectivity. This does not mean every regulatory affairs role now requires deep security expertise; plenty of device categories have limited or no connectivity and are largely unaffected. But for companies working on connected products, the ability to speak credibly to cybersecurity submission content has become a genuine hiring differentiator, and candidates who can point to real experience assembling this kind of submission section, even a single one, stand out in a hiring pool where most applicants have none.
Some larger device companies have responded by creating a dedicated regulatory role focused specifically on software and cybersecurity submissions, distinct from the generalist regulatory affairs specialist role, reporting either into regulatory affairs or jointly with quality and security functions. Smaller companies more often fold this responsibility into an existing regulatory affairs role, which means the specialist or manager handling it is learning largely on the job, often by working closely with an outside cybersecurity consultant on the first submission or two. Either path is a reasonable way into this niche, and neither requires starting over in a security-specific career; it requires a regulatory affairs professional willing to get genuinely comfortable with unfamiliar technical vocabulary.
Why This Work Is Hard to Outsource Entirely
It is tempting for a company to treat cybersecurity submission content as something a specialized consultant can simply produce and hand over, and consultants do play a real and useful role, particularly for a company's first submission in this area. But the postmarket obligations that follow clearance are ongoing and internal by nature, and a consultant who is not embedded in the company cannot own a vulnerability monitoring process that has to function continuously, years after the original submission team has moved on to other projects. Companies that treat this purely as an outsourced deliverable often find themselves without a workable internal process when the first postmarket vulnerability disclosure actually arrives, which is exactly the moment a defensible, well-documented process matters most. This is part of why the internal hiring need is real rather than a temporary bubble driven by one-time submission demand.
It also means the internal regulatory affairs owner of this work needs enough standing within the organization to keep the cross-functional process alive during the long stretches when nothing urgent is happening. A vulnerability monitoring process that only gets attention when a submission is due, and is otherwise neglected, tends to fail exactly when it is tested. Building the habit of periodic internal check-ins with the security function, even when there is no active submission driving the conversation, is a less visible but genuinely important part of doing this work well.
Building This Expertise Without a Security Background
For a regulatory affairs professional who wants to move into this space, the most direct path is exposure: asking to sit in on a security risk assessment, reviewing a software bill of materials with the engineer who compiled it and asking what each entry actually means, and reading a cleared submission's cybersecurity section from a comparable device, when one is publicly available, to see how another company structured the content. This is not a credential-driven specialization in the way that quality systems or clinical affairs sometimes are; there is no widely recognized certification that reliably signals competence here yet, which means direct submission experience and the ability to talk through it clearly in an interview currently matter more than any formal training a candidate could point to.
It is also worth reading FDA's published cybersecurity guidance documents directly rather than relying only on secondhand summaries. These documents are written for a technical and regulatory audience at once, and working through one carefully, section by section, is one of the more efficient ways to build a working vocabulary in this area without a formal course. Pairing that reading with a real conversation with an internal security engineer, even an informal one, tends to make the material click in a way that reading alone does not.
Conclusion
Medical device cybersecurity has moved from an engineering afterthought to a formal, ongoing regulatory affairs responsibility, and the companies making connected devices are actively looking for people who can operate at that intersection. This is a genuine growth area within device regulatory affairs rather than a passing trend, since the connectivity driving the requirement is only becoming more common, not less. Regulatory professionals who build real fluency here, even without a security background, are positioning themselves for a niche that is short on experienced candidates and likely to stay that way for some time.